Bioconversion and biosynthesis of 16-membered macrolide antibiotics. X. Final steps in the biosynthesis of spiramycin, using enzyme inhibitor: cerulenin. - Suppr | 超能文献

Bioconversion and biosynthesis of 16-membered macrolide antibiotics. X. Final steps in the biosynthesis of spiramycin, using enzyme inhibitor: cerulenin.

作者信息

Omura S, Kitao C, Hamada H, Ikeda H

出版信息

Chem Pharm Bull (Tokyo). 1979 Jan;27(1):176-82. doi: 10.1248/cpb.27.176.

DOI:10.1248/cpb.27.176

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Bioconversion and biosynthesis of 16-membered macrolide antibiotics. X. Final steps in the biosynthesis of spiramycin, using enzyme inhibitor: cerulenin.

Chem Pharm Bull (Tokyo). 1979 Jan;27(1):176-82. doi: 10.1248/cpb.27.176.

2

Bioconversion and biosynthesis of 16-membered macrolide antibiotics. XIII. Regulation of spiramycin I 3-hydroxyl acylase formation by glucose, butyrate, and cerulenin.

J Antibiot (Tokyo). 1979 Jun;32(6):593-9. doi: 10.7164/antibiotics.32.593.

3

Bioconversion and biosynthesis of 16-membered macrolide antibiotic, tylosin, using enzyme inhibitor: cerulenin.使用酶抑制剂：浅蓝菌素进行16元大环内酯类抗生素泰乐菌素的生物转化和生物合成。

J Antibiot (Tokyo). 1978 Mar;31(3):254-6. doi: 10.7164/antibiotics.31.254.

4

Inhibition of the biosynthesis of leucomycin, a macrolide antibiotic, by cerulenin.浅蓝菌素对大环内酯类抗生素柱晶白霉素生物合成的抑制作用。

J Biochem. 1977 Apr;81(4):1127-32. doi: 10.1093/oxfordjournals.jbchem.a131537.

5

Bioconversion and biosynthesis of 16-membered macrolide antibiotics. XV. Final steps in the biosynthesis of leucomycins.

J Antibiot (Tokyo). 1979 Oct;32(10):1055-7. doi: 10.7164/antibiotics.32.1055.

6

Bioconversion and biosynthesis of nanaomycins using cerulenin, a specific inhibitor of fatty acid and polyketide biosyntheses.使用脂肪酸和聚酮化合物生物合成的特异性抑制剂浅蓝菌素进行纳那霉素的生物转化和生物合成。

J Antibiot (Tokyo). 1980 Jul;33(7):711-6. doi: 10.7164/antibiotics.33.711.

7

Hybrid biosynthesis of derivatives of protylonolide and M-4365 by macrolide-producing microorganisms.大环内酯类产生菌对原内酯醇和M-4365衍生物的杂交生物合成

J Antibiot (Tokyo). 1982 Jun;35(6):680-7. doi: 10.7164/antibiotics.35.680.

8

Specific inhibition of candicidin biosynthesis by the lipogenic inhibitor cerulenin.产脂抑制剂浅蓝菌素对杀假丝菌素生物合成的特异性抑制作用。

Biochim Biophys Acta. 1975 Dec 5;411(2):186-94. doi: 10.1016/0304-4165(75)90298-6.

9

[Acylation specificity of midecamycin 3-O-acyltransferase within Streptomyces spiramyceticus F21].[螺旋霉素链霉菌F21中麦迪霉素3 - O - 酰基转移酶的酰化特异性]

Sheng Wu Gong Cheng Xue Bao. 2008 Dec;24(12):2086-92.

10

Biosynthesis of fattiviracin FV-8, an antiviral agent.

Biosci Biotechnol Biochem. 2001 Apr;65(4):861-4. doi: 10.1271/bbb.65.861.

引用本文的文献

1

Post-PKS tailoring steps of the spiramycin macrolactone ring in Streptomyces ambofaciens.链霉菌 ambofaciens 中螺旋霉素大环内酯环的 PKS 后修饰步骤。

Antimicrob Agents Chemother. 2013 Aug;57(8):3836-42. doi: 10.1128/AAC.00512-13. Epub 2013 May 28.

2

Enzymes of secondary metabolism and the biosynthesis of macrolide antibiotics.次生代谢酶与大环内酯类抗生素的生物合成

Folia Microbiol (Praha). 1986;31(5):402-21. doi: 10.1007/BF02936606.

3

Branched-chain fatty acids produced by mutants of Streptomyces fradiae, putative precursors of the lactone ring of tylosin.弗氏链霉菌突变体产生的支链脂肪酸，泰乐菌素内酯环的假定前体。

Antimicrob Agents Chemother. 1990 Aug;34(8):1535-41. doi: 10.1128/AAC.34.8.1535.